Darden Wealth Group
ABBV icon

Darden Wealth Group’s AbbVie ABBV Stock Holding History

Darden Wealth Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.24M Sell
4,753
-29
-0.6% -$7.43K 0.5% 41
2026
Q2 		$1.2M Buy
4,782
+7
+0.1% +$1.51K 0.48% 49
2026
Q1 		$1.04M Hold
4,775
– – 0.53% 42
2025
Q4 		$1.09M Buy
4,775
+148
+3% +$33.7K 0.53% 48
2025
Q3 		$1.07M Hold
4,627
– – 0.56% 45
2025
Q2 		$859K Sell
4,627
-205
-4% -$38.1K 0.52% 50
2025
Q1 		$1.01M Hold
4,832
– – 0.78% 37
2024
Q4 		$859K Buy
4,832
+100
+2% +$18.4K 0.58% 43
2024
Q3 		$934K Buy
4,732
+155
+3% +$28.9K 0.67% 39
2024
Q2 		$785K Buy
4,577
+418
+10% +$69.2K 0.47% 41
2024
Q1 		$757K Buy
4,159
+2,168
+109% +$374K 0.59% 49
2023
Q4 		$309K Buy
+1,991
New +$290K 0.3% 72

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Darden Wealth Group's ABBV Position: Q3 2026 in Review

Darden Wealth Group reduced its AbbVie (ABBV) stake by 0.61% in Q3 2026, selling an estimated $7.43K and leaving 4,753 shares worth $1.24M. The position accounts for 0.5% of the portfolio, ranked #41.

Darden Wealth Group first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Darden Wealth Group held 4,753 shares of AbbVie worth $1.24M as of Q3 2026.
  • Darden Wealth Group sold 29 AbbVie shares in Q3 2026, an estimated $7.43K.
  • AbbVie made up 0.5% of Darden Wealth Group's portfolio in Q3 2026, its #41 holding.
  • Darden Wealth Group first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Darden Wealth Group's 13F filing for Q3 2026, filed 6 Nov 2026.